Escitalopram-induced liver injury: A case report and review of literature

doi:10.4254/wjh.v11.i10.719

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 10

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (11870)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-1) series.

Item

Count

PDF

324

WORD

223

HTML

8968

Figures (1-2)

229

Tables (1-1)

220

Sum=9964

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

727

Download

1179

Sum=1906

Oct 27, 2019 (publication date) through Oct 2, 2024

Times Cited of This Article

Times Cited (7)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Hepatol. Oct 27, 2019; 11(10): 719-724
Published online Oct 27, 2019. doi: 10.4254/wjh.v11.i10.719

Full Size Figure Download Figure

Figure 2 Hepatic metabolism of escitalopram; S-demethylcitalopram, the principal metabolite, is present at one-third the level of escitalopram and the didemethyl metabolite of escitalopram is typically present at or below quantifiable concentrations.

Citation: Ng QX, Yong CSK, Loke W, Yeo WS, Soh AYS. Escitalopram-induced liver injury: A case report and review of literature. World J Hepatol 2019; 11(10): 719-724
URL: https://www.wjgnet.com/1948-5182/full/v11/i10/719.htm
DOI: https://dx.doi.org/10.4254/wjh.v11.i10.719